Global Pharma’s Repeated Alzheimer’s Drug Failures Open New Opportunities for Korean Biotechs As global pharmaceutical giants such as Johnson & Johnson (J&J) and Novo Nordisk face setbacks in developing Alzheimer’s… Park Pyeongtak 2025-12-02